Summary: The Centers for Medicare & Medicaid Services modified its endothelial cell photography coverage policy, effective May 15, 2026. Here's what billing teams need to know before claims start hitting.
CMS endothelial cell photography coverage policy changes don't come up often, but when they do, they tend to catch ophthalmology billing teams off guard. The Centers for Medicare & Medicaid Services has updated its policy governing specular microscopy and endothelial cell imaging — the diagnostic photography used to evaluate corneal endothelial cell density and health. This policy does not carry a numbered policy code in the CMS system. The specific CPT codes affected are not listed in the published policy document, which we'll address directly below.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Centers for Medicare & Medicaid Services (CMS) |
| Policy | Endothelial Cell Photography |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | Medium |
| Specialties Affected | Ophthalmology, corneal surgery, cataract surgery programs |
| Key Action | Review your current documentation practices for corneal endothelial imaging before May 15, 2026, and confirm your Medicare Administrative Contractor's local coverage determination still aligns with this update |
CMS Endothelial Cell Photography Coverage Criteria and Medical Necessity Requirements 2026
Endothelial cell photography — also called specular microscopy — captures images of the corneal endothelium to assess cell density, morphology, and overall corneal health. CMS covers this service when it meets medical necessity criteria, meaning there must be a documented clinical reason to evaluate the endothelium beyond routine preoperative screening.
The coverage policy has historically required that endothelial cell photography be ordered in the context of a condition that directly affects corneal endothelial function. That includes Fuchs' endothelial dystrophy, bullous keratopathy, prior intraocular surgery with documented endothelial cell loss, and evaluation before corneal transplantation. Repeat studies are covered when the results will materially change clinical management — not simply to monitor a stable condition without treatment implications.
Medical necessity is the hinge point for these claims. CMS does not cover endothelial imaging performed as a general preoperative screen for routine cataract surgery in patients with no known endothelial pathology. That's where denials concentrate. If your surgeons are ordering specular microscopy on every cataract patient without documented clinical justification, expect claim denial rates to climb after May 15, 2026.
Prior authorization is not typically required under Medicare for diagnostic imaging of this type, but your Medicare Administrative Contractor may have local coverage determination language that adds requirements. Check your MAC's LCD before the effective date — this is not a step to skip.
Whether endothelial cell photography is covered under Medicare depends entirely on the diagnosis driving the order. The ICD-10 codes on your claim need to tell a complete story. A claim billed with a routine cataract diagnosis and no corneal dystrophy or prior surgical complication documented will not survive scrutiny under this coverage policy.
CMS Endothelial Cell Photography Exclusions and Non-Covered Indications
CMS does not cover endothelial cell photography as a routine screening tool. The word "routine" is doing a lot of work in that sentence — and it's worth being precise about what that means in practice.
Specular microscopy ordered solely as part of a standard preoperative cataract workup, without any clinical indication pointing to endothelial disease or risk, is not a covered service under Medicare. The payer's position is that routine preoperative screening of the endothelium does not meet the medical necessity threshold when there is no documented pathology or elevated risk factor.
Repeat imaging on a stable, asymptomatic condition — where results won't change the treatment plan — also falls outside covered indications. CMS expects that each study ordered has a direct bearing on clinical decision-making. If your documentation doesn't show how the imaging result will affect management, that claim is vulnerable.
Cosmetic or refractive surgery contexts are excluded as well. Endothelial cell photography ordered in support of elective refractive procedures is not a Medicare benefit. Make sure your billing team isn't inadvertently pulling these into Medicare claims.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Fuchs' endothelial dystrophy — evaluation and management monitoring | Covered | Confirm with your MAC's LCD | Medical necessity documentation required |
| Bullous keratopathy | Covered | Confirm with your MAC's LCD | Clinical documentation must support repeat studies |
| Pre-corneal transplant evaluation | Covered | Confirm with your MAC's LCD | Must show direct bearing on surgical planning |
| Prior intraocular surgery with documented endothelial cell loss | Covered | Confirm with your MAC's LCD | Document specific prior procedure and current cell count |
| Routine preoperative cataract screening (no endothelial pathology) | Not Covered | N/A | Does not meet medical necessity threshold |
| Stable, asymptomatic endothelial condition — repeat monitoring without treatment implications | Not Covered | N/A | Repeat studies require documented management change rationale |
| Cosmetic or elective refractive surgery context | Not Covered | N/A | Not a Medicare benefit in refractive surgery settings |
CMS Endothelial Cell Photography Billing Guidelines and Action Items 2026
The published policy document does not list specific CPT or HCPCS codes. That's a real problem for billing teams trying to map this update to their charge capture. Here's how to handle the gap and what to do before May 15, 2026.
| # | Action Item |
|---|---|
| 1 | Pull your MAC's local coverage determination now. CMS national policy sets the framework, but your MAC's LCD governs the specific CPT codes, diagnosis code pairings, and documentation requirements for endothelial cell photography billing in your region. Don't wait until May 14 to find out your MAC has added criteria. Contact your MAC directly or search their LCD database for "specular microscopy" or "endothelial cell photography." |
| 2 | Audit claims from the last 12 months for denial patterns. Pull every claim your practice submitted for endothelial cell imaging over the past year. Flag any that went through without a documented diagnosis tied to known endothelial pathology. Those claims represent your current exposure — and they show you where your pre-billing review is breaking down. |
| 3 | Update your charge capture documentation checklist before May 15, 2026. Every order for endothelial cell photography should require the ordering provider to document the specific clinical indication, the endothelial condition or risk factor driving the study, and how the result will affect clinical management. Build this into your intake workflow, not as an afterthought at claim submission. |
| 4 | Brief your ophthalmologists on the non-covered indications. The biggest reimbursement risk here is surgeons who routinely order specular microscopy on cataract patients without documented endothelial pathology. Have a direct conversation about which patients actually need this study versus which are getting it as a matter of habit. This isn't about denying necessary care — it's about protecting the practice from claim denial and potential recoupment. |
| 5 | Review your ICD-10 code pairings for specular microscopy claims. Your diagnosis codes need to map cleanly to a covered indication. If you're consistently seeing a mismatch between the ordered procedure and the diagnosis driving the order, your coding team needs to flag that for the ordering physician before the claim goes out. A covered clinical scenario documented poorly will still generate a denial. |
| 6 | Talk to your compliance officer if you're unsure about your current volume. If endothelial cell photography makes up a significant share of your diagnostic billing and you're not confident your documentation practices align with the updated coverage policy, loop in your compliance officer before the effective date. This is exactly the kind of policy modification that can turn a documentation habit into a billing problem at scale. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Endothelial Cell Photography Under This Policy
The published CMS policy document for this modification does not list specific CPT, HCPCS, or ICD-10 codes. This is not unusual for CMS-level policy updates, which often set coverage principles while leaving code-specific guidance to the Medicare Administrative Contractor level via local coverage determinations.
What this means for your billing team: Do not assume a code is covered or excluded based solely on the national policy language. Your MAC's LCD is the controlling document for code-level billing guidelines in your region.
How to Find the Applicable Codes
Contact your MAC directly or search your MAC's website for local coverage determinations tied to "specular microscopy," "corneal endothelial cell photography," or "endothelial imaging." MACs with high ophthalmology claim volumes — Novitas, WPS, CGS, and Noridian — tend to have more detailed LCD language on diagnostic ophthalmic procedures.
Ask your MAC specifically:
- Which CPT codes they recognize for specular microscopy and endothelial cell photography
- Which ICD-10 diagnosis codes they accept as supporting medical necessity for each CPT code
- Whether any covered CPT codes for this service require an advance beneficiary notice (ABN) for specific indications
A Note on Code Integrity
We don't publish codes we can't verify from the source document. If this post listed CPT codes without confirming them from the actual policy data, that creates a compliance risk for your team — you might bill a code that isn't covered, or miss a code that is. Get the code list from your MAC, not from a blog post that's guessing.
If you have access to the full policy document through your MAC's LCD portal or through a service like PayerPolicy, pull the actual code tables before updating your charge capture.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.